Participate in research for Ovarian Cancer
Tell us what's important to you as someone living with Ovarian Cancer.
Your participation is valuable in exploring the treatment preferences for people living with Ovarian Cancer. This information will help researchers understand what treatment goals are important to people with this condition. You will receive an $50 egift card in recognition of your time and contribution to this research.
Who can participate:
We are looking for people over 18 years of age who have been diagnosed with Ovarian Cancer.
*Please note other eligibility criteria will apply.
What is involved:
Eligible participants complete a 25 minute online survey using their phone, computer or tablet device.
Talk to our Team
If you take part in this research study, there will be:
Convenience
Complete the survey from the comfort of your own home
Contribution to medical research
Help investigate a potential new treatment that could improve the lives of individuals with coeliac disease
Register your interest now
or scroll down to read the study FAQs
Study Guide
01
Who can take part in this study?
-
We are looking for people over 18 years of age who have been diagnosed with Ovarian Cancer.
02
Who is unable to take part in this study?
+
Unfortunately, if any of the following apply to you, this study is not the right fit for you:
- Are under the age of 18
- Have not been diagnosed with Ovarian Cancer
Please note, additional eligibility criteria apply.
03
What does the study involve for participants?
+
Eligible participants can complete the 25 minute online survey using their phone, computer or tablet device
04
What is the purpose of this study?
+
CaPPRe is working on behalf of a pharmaceutical company to conduct an online survey with people diagnosed with ovarian cancer in Australia to understand what treatment goals are important to people. The pharmaceutical company is not involved in conducting the research or analysing the results.
CaPPRe are specialists in 'preference research' which examines what people living with certain health conditions value and prioritise in treatments.
The results of the research may be used to support submissions that aim to expand access to new treatments in ovarian cancer and may also inform the development of new products and services in the future.
05
What is Ovarian Cancer?
+
Ovarian cancer is a type of cancer that begins in the ovaries, the female reproductive glands responsible for producing eggs and hormones like estrogen and progesterone. It often goes undetected in its early stages because symptoms can be vague or easily mistaken for other common conditions, such as bloating, abdominal discomfort, or changes in bowel habits. As a result, ovarian cancer is frequently diagnosed at a more advanced stage, which can make it more difficult to treat.
06
Why is this study important?
+
The results of the research may be used to support submissions that aim to expand access to new treatments in ovarian cancer and may also inform the development of new products and services in the future.
07
Who is sponsoring this study?
+
This study is being sponsored by Community and Patient Preference Research (CaPPRe), an independent research organisation.
08
What if I have other questions about the study?
+
We are here for you! Head to our Evrima Help Centre and search for answers relating to clinical trials, study information and managing your Evrilink account
This study has been approved by an independent Human Research Ethics Committee
Help make medical research breakthroughs happen.
Need help with clinical trial information?
Search our Evrima help Centre for answers related to information about our active studies, information about managing your Evrilink account, and general clinical trial knowledge!
Read our FAQs